Poisons Amendment (Monitored Medicines) Regulations 2022
I, the Governor in and over the State of Tasmania and its Dependencies in the Commonwealth of Australia, acting with the advice of the Executive Council, make the following regulations under the Poisons Act 1971 .
20 June 2022B. BAKER
Governor
By Her Excellency's Command,
JEREMY ROCKLIFF
Minister for Health
These regulations may be cited as the Poisons Amendment (Monitored Medicines) Regulations 2022 .
These regulations take effect on 1 July 2022.
In these regulations, the Poisons Regulations 2018 are referred to as the Principal Regulations.
4. Regulation 95B substituted
Regulation 95B of the Principal Regulations is rescinded and the following regulation is substituted:95B. Prescribed monitored medicines
(1) For the purposes of paragraph (b) of the definition of monitored medicines in section 3(1) of the Act, the following are prescribed to be monitored medicines:(a) codeine (S4);(b) dextropropoxyphene;(c) gabapentin;(d) olanzapine;(e) pregabalin;(f) quetiapine;(g) tramadol;(h) zolpidem;(i) zopiclone.(2) For the purposes of paragraph (c) of the definition of monitored medicines in section 3(1) of the Act, substances that are in the class of substances known as benzodiazepines are prescribed to be monitored medicines.
Displayed and numbered in accordance with the Rules Publication Act 1953.
Notified in the Gazette on 29 June 2022
These regulations are administered in the Department of Health.
EXPLANATORY NOTE
(This note is not part of the regulation)
These regulations amend the Poisons Regulations 2018 by specifying certain substances, and certain classes of substances, to be monitored medicines for the purposes of the Poisons Act 1971.